Prudential Financial
CLSD

Prudential Financial’s Clearside Biomedical CLSD Stock Holding History

Prudential Financial’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,627
Closed -$22.4K – 2439
2025
Q1 		$22.4K Buy
1,627
+334
+26% +$4.79K ﹤0.01% 2248
2024
Q4 		$18.4K Sell
1,293
-1,067
-45% -$17.5K ﹤0.01% 2273
2024
Q3 		$45K Hold
2,360
– – ﹤0.01% 2657
2024
Q2 		$46K Buy
2,360
+1,013
+75% +$19.6K ﹤0.01% 2621
2024
Q1 		$30.9K Buy
+1,347
New +$29K ﹤0.01% 2631
2019
Q1 		– Sell
-895
Closed -$14K – 2435
2018
Q4 		$14K Buy
+895
New +$42K ﹤0.01% 2369

Other funds holding CLSD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Prudential Financial's CLSD Position: Q2 2025 in Review

Prudential Financial sold out of Clearside Biomedical (CLSD) in Q2 2025, closing a stake of 1,627 shares — an estimated $22.4K sold.

Prudential Financial first reported a position in CLSD in Q4 2018 and held it in 6 quarters. The position peaked at $46K in Q2 2024. 44 funds tracked by Wall St. Rank hold CLSD as of Q2 2025.

  • Prudential Financial reported no remaining Clearside Biomedical position as of Q2 2025 after selling out during the quarter.
  • Prudential Financial sold 1,627 Clearside Biomedical shares in Q2 2025, an estimated $22.4K.
  • Prudential Financial first reported a position in Clearside Biomedical in Q4 2018 and held it in 6 quarters.
  • Prudential Financial's Clearside Biomedical position peaked at $46K in Q2 2024.
  • 44 funds tracked by Wall St. Rank held Clearside Biomedical as of Q2 2025.

Based on Prudential Financial's 13F filing for Q2 2025, filed 12 Aug 2025.